Latest Insider Transactions at Petmed Express Inc (PETS)
This section provides a real-time view of insider transactions for Petmed Express Inc (PETS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PETMED EXPRESS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PETMED EXPRESS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 28
2022
|
Peter Cobb Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+33.33%
|
$157,500
$21.76 P/Share
|
|
Jul 28
2022
|
Leslie C.G. Campbell Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+15.79%
|
$157,500
$21.76 P/Share
|
|
Jan 11
2022
|
Jodi Watson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+18.01%
|
$62,500
$25.2 P/Share
|
|
Jan 11
2022
|
Leslie C.G. Campbell Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+7.14%
|
$62,500
$25.2 P/Share
|
|
Jul 30
2021
|
Bruce S Rosenbloom Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,925
+24.72%
|
$462,675
$31.39 P/Share
|
|
Jul 30
2021
|
Gian Fulgoni Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+10.95%
|
$232,500
$31.39 P/Share
|
|
Jul 30
2021
|
Jodi Watson Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+45.79%
|
$232,500
$31.39 P/Share
|
|
Jul 30
2021
|
Leslie C.G. Campbell Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+20.0%
|
$232,500
$31.39 P/Share
|
|
Jul 30
2021
|
Ronald J Korn Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+7.63%
|
$232,500
$31.39 P/Share
|
|
Jun 02
2021
|
Bruce S Rosenbloom Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,000
-16.43%
|
$252,000
$42.5 P/Share
|
|
Jan 29
2021
|
Frank J Formica Director |
SELL
Open market or private sale
|
Direct |
5,000
-8.33%
|
$190,000
$38.59 P/Share
|
|
Jan 28
2021
|
Gian Fulgoni Director |
SELL
Open market or private sale
|
Direct |
2,890
-5.12%
|
$144,500
$50.93 P/Share
|
|
Jan 28
2021
|
Bruce S Rosenbloom Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-12.04%
|
$250,000
$50.0 P/Share
|
|
Jan 27
2021
|
Gian Fulgoni Director |
SELL
Open market or private sale
|
Direct |
10,000
-15.06%
|
$460,000
$46.03 P/Share
|
|
Jan 27
2021
|
Menderes Akdag CEO & President |
SELL
Open market or private sale
|
Direct |
60,000
-15.08%
|
$2,700,000
$45.5 P/Share
|
|
Jan 13
2021
|
Ronald J Korn Director |
SELL
Open market or private sale
|
Direct |
2,000
-2.34%
|
$70,000
$35.0 P/Share
|
|
Dec 24
2020
|
Ronald J Korn Director |
SELL
Open market or private sale
|
Direct |
2,000
-2.29%
|
$68,000
$34.0 P/Share
|
|
Dec 18
2020
|
Ronald J Korn Director |
SELL
Open market or private sale
|
Direct |
2,000
-2.24%
|
$66,000
$33.0 P/Share
|
|
Nov 12
2020
|
Ronald J Korn Director |
SELL
Open market or private sale
|
Direct |
2,000
-2.19%
|
$64,000
$32.0 P/Share
|